Early Stage Venture Senda Biosciences Raises Series A of $88000000

October 28, 2020

About Senda Biosciences

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

Website: Learn more on Senda Biosciences’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Senda Biosciences

Amount Raised88000000 USD
Announced Date2020-10-28
Equity Only FundingYes
Organization LocationCambridge, Massachusetts, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsFlagship Pioneering
Number of Investors1
Number of Partner Investors1
Previous Story

Early Stage Venture Kandji Raises Series A of $21000000

Next Story

Early Stage Venture Homethrive Raises Series A of $18000000